EXAS vs ZBAI · rev $2.76B vs rev $620.0K
EXACT Sciences Corporation (EXAS) versus ATIF Holdings Limited (ZBAI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
ATIF Holdings Limited (ZBAI) is a capital markets company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported ZBAI revenue for 2024-07-31 was $620.0K. Net income was -$3.2M. ZBAI currently screens at market cap $18.6M.
EXAS currently screens at market cap $20.03B. ZBAI currently screens at market cap $18.6M.
Not investment advice. Open the EXAS and ZBAI stock pages for the full models.
Not investment advice.